CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma

Condition:   Pancreatic Cancer Intervention:   Drug: CEND-1 Sponsors:   Qilu Pharmaceutical Co., Ltd.;   Cend Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials